1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Partial Lipodystrophy: new trials by email Literature Review of Partial Lipodystrophy trials Research Report on Partial Lipodystrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance Pegvisomant - Insulin Receptor Mutation, Partial Lipodystrophy | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 25 | 2023-01-23 | 2026-08-18 |
Insulin Resistance (1) · Lipodystrophy, Partial, Acquired (1)
Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
pegvisomant (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
United States (1)